Published February 2000
| Version v1
Journal article
Clinical application of somatostatin receptor scintigraphy in medullary thyroid carcinoma
Description
Objective: To study the value of somatostatin receptor scintigraphy (SRS) for medullary thyroid carcinoma (MTC). Methods: SRS was performed in 10 patients with MTC, whole-body scan and planner images were acquired at 4 and 24 h after intravenous injection of 111∼185 MBq of 111In-octreotide. Results: 7 of 9 patients with elevated calcitonin had positive SRS results, and 1 patient with normal calcitonin had positive SRS results. The sensitivity was 77.8%. Conclusion: SRS is a useful method to locate MTC lesions
Additional details
Publishing Information
- Journal Title
- Chinese Journal of Nuclear Medicine
- Journal Volume
- 20
- Journal Issue
- 1
- Journal Page Range
- p. 3-4
- ISSN
- 0253-9780
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 31032062
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; DIAGNOSIS; IMAGES; INDIUM 111; RECEPTORS; SCINTISCANNING; SOMATOSTATIN; THYROID
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BODY; COUNTING TECHNIQUES; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; ENDOCRINE GLANDS; GLANDS; INDIUM ISOTOPES; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MINUTES LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPE SCANNING; RADIOISOTOPES